• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Disease Duration in Patients Recruited to Psoriasis Phase III Trials: A Systematic Review.

作者信息

Branyiczky Miranda K, Mehta Shanti, Vender Ronald

机构信息

Michael G. DeGroote School of Medicine, McMaster University, 1280 Main St W, Hamilton, ON, L8S 4L8, Canada.

Temerty Faculty of Medicine, University of Toronto, Toronto, ON, Canada.

出版信息

Am J Clin Dermatol. 2025 Jul 2. doi: 10.1007/s40257-025-00959-3.

DOI:10.1007/s40257-025-00959-3
PMID:40601243
Abstract
摘要

相似文献

1
Disease Duration in Patients Recruited to Psoriasis Phase III Trials: A Systematic Review.银屑病III期试验招募患者的疾病持续时间：一项系统评价
Am J Clin Dermatol. 2025 Jul 2. doi: 10.1007/s40257-025-00959-3.
2
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.系统性药理学治疗慢性斑块状银屑病：网络荟萃分析。
Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4.
3
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.慢性斑块状银屑病的全身药理学治疗：一项网状Meta分析。
Cochrane Database Syst Rev. 2020 Jan 9;1(1):CD011535. doi: 10.1002/14651858.CD011535.pub3.
4
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.系统性药理学治疗慢性斑块型银屑病：网络荟萃分析。
Cochrane Database Syst Rev. 2022 May 23;5(5):CD011535. doi: 10.1002/14651858.CD011535.pub5.
5
The evolving demographics of participants in psoriatic arthritis phase III randomised controlled trials of b/tsDMARDs: A systematic review.银屑病关节炎生物制剂/靶向合成改善病情抗风湿药（b/tsDMARDs）III期随机对照试验参与者的人口统计学特征演变：一项系统评价。
Semin Arthritis Rheum. 2023 Jun;60:152175. doi: 10.1016/j.semarthrit.2023.152175. Epub 2023 Feb 14.
6
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.慢性斑块状银屑病的全身药理学治疗：一项网状荟萃分析。
Cochrane Database Syst Rev. 2017 Dec 22;12(12):CD011535. doi: 10.1002/14651858.CD011535.pub2.
7
Etanercept and efalizumab for the treatment of psoriasis: a systematic review.依那西普和依法利珠单抗治疗银屑病：一项系统评价。
Health Technol Assess. 2006 Nov;10(46):1-233, i-iv. doi: 10.3310/hta10460.
8
A Review of Topical Roflumilast for the Treatment of Plaque Psoriasis.外用罗氟司特治疗斑块状银屑病的综述
Ann Pharmacother. 2023 Aug;57(8):966-969. doi: 10.1177/10600280221137750. Epub 2022 Nov 24.
9
Combination regimens of topical calcipotriene in chronic plaque psoriasis: systematic review of efficacy and tolerability.慢性斑块状银屑病中局部用卡泊三醇联合治疗方案：疗效和耐受性的系统评价
Arch Dermatol. 2000 Dec;136(12):1536-43. doi: 10.1001/archderm.136.12.1536.
10
Efficacy of psoralen UV-A therapy vs. narrowband UV-B therapy in chronic plaque psoriasis: a systematic literature review.补骨脂素长波紫外线疗法与窄谱中波紫外线疗法治疗慢性斑块型银屑病的疗效比较：系统文献回顾。
J Eur Acad Dermatol Venereol. 2012 May;26 Suppl 3:11-21. doi: 10.1111/j.1468-3083.2012.04519.x.

本文引用的文献

1
Comparison of Drug-Free Remission after the End of Phase III Trials of Three Different Anti-IL-23 Inhibitors in Psoriasis.三种不同抗白细胞介素-23抑制剂治疗银屑病III期试验结束后无药缓解情况的比较
Dermatol Ther (Heidelb). 2024 Sep;14(9):2607-2620. doi: 10.1007/s13555-024-01229-6. Epub 2024 Jul 29.
2
Investigation of plaque psoriasis relapse after secukinumab withdrawal in patients from two phase III studies.两项 III 期研究中司库奇尤单抗停药后斑块状银屑病复发的调查。
Clin Exp Dermatol. 2024 Jul 19;49(8):793-800. doi: 10.1093/ced/llad329.
3
No impact of disease duration on response to tildrakizumab treatment among patients with moderate-to-severe plaque psoriasis: Post hoc analyses from two phase 3 (reSURFACE 1 and reSURFACE 2) and one phase 4 (TRIBUTE) studies.
中度至重度斑块状银屑病患者中疾病持续时间对替拉珠单抗治疗反应无影响：两项3期（reSURFACE 1和reSURFACE 2）和一项4期（TRIBUTE）研究的事后分析
Skin Health Dis. 2023 Jun 28;3(5):e263. doi: 10.1002/ski2.263. eCollection 2023 Oct.
4
Early disease intervention with guselkumab in psoriasis leads to a higher rate of stable complete skin clearance ('clinical super response'): Week 28 results from the ongoing phase IIIb randomized, double-blind, parallel-group, GUIDE study.在银屑病中早期使用古塞库单抗进行疾病干预可导致更高的稳定完全皮肤清除率（“临床超级应答”）：正在进行的 IIIb 期随机、双盲、平行组、GUIDE 研究的第 28 周结果。
J Eur Acad Dermatol Venereol. 2023 Oct;37(10):2016-2027. doi: 10.1111/jdv.19236. Epub 2023 Jul 18.
5
Could Targeted Pharmacotherapies Exert a "Disease Modification Effect" in Patients with Chronic Plaque Psoriasis?靶向药物治疗能否对慢性斑块状银屑病患者产生“疾病修饰作用”？
Int J Mol Sci. 2022 Oct 25;23(21):12849. doi: 10.3390/ijms232112849.
6
CD8 resident memory T cells with interleukin 17A-producing potential are accumulated in disease-naïve nonlesional sites of psoriasis possibly in correlation with disease duration.具有产生白细胞介素17A潜能的CD8组织驻留记忆T细胞在银屑病未患病的非皮损部位积聚，这可能与病程有关。
Br J Dermatol. 2019 Aug;181(2):410-412. doi: 10.1111/bjd.17748. Epub 2019 May 29.
7
The journey of adult psoriasis patients towards biologics: past and present - Results from the BioCAPTURE registry.成人银屑病患者接受生物制剂治疗的历程：过去和现在——来自 BioCAPTURE 登记研究的结果。
J Eur Acad Dermatol Venereol. 2018 Apr;32(4):615-623. doi: 10.1111/jdv.14684. Epub 2017 Dec 26.